Publications by authors named "Eduardo Fernandez-Carracedo"
Article Synopsis
- Some COVID-19 patients with pneumonia experience a cytokine storm that worsens their condition, potentially benefiting from anti-inflammatory treatments like colchicine.
- A trial involving 240 hospitalized patients tested the effectiveness of colchicine compared to standard care in reducing serious outcomes (like mechanical ventilation and death).
- The results showed no significant difference in outcomes between those treated with colchicine and the control group, indicating that colchicine did not offer any additional clinical benefits.
Background: Since December 2019, the COVID-19 pandemic has changed the concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital due to SARS-CoV-2 infection.
Methods: This work analyzes the use and effectiveness of antibiotics in hospitalized patients with COVID-19 based on data from the SEMI-COVID-19 registry, an initiative to generate knowledge about this disease using data from electronic medical records.
Background: Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-infections are rare. This can lead to increased complications, including antibacterial resistance. We aim to analyze risk factors for inappropriate antibiotic prescription in these patients and describe possible complications arising from their use.
View Article and Find Full Text PDFAims: The association of on-admission CRP and early adverse outcomes in acute venous thromboembolism (VTE) has not been investigated. We hypothesized that increased on-admission CRP levels would correlate with adverse outcomes in patients with acute VTE.
Method: In this prospective observational study, consecutive patients with acute VTE were enrolled and CRP levels were measured within the first 24h after diagnosis.